-
Increased cancer risk not seen in metal-on-metal hip replacement systems
- Apr 10, 2012
-
Popular MS treatment may not prevent disability
- Jul 19, 2012
-
Lawsuits force Johnson & Johnson to work as a team
- Jul 12, 2012
-
Johnson & Johnson reduces Tylenol dosage requirements
- Dec 29, 2011
-
FDA issues warning to sports supplement drink manufacturers
- May 4, 2012
-
Documents reveal three FDA advisory panel members previously worked for Bayer
- Jan 18, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
GlaxoSmithKline internal bleeding pulomonary embolism MenHibrix Johnson & Johnson Tutorials Urban chemotherapy EMA Accutane Nature metal on metal hip replacement Nexavar Xarelto stroke Johnson & Johnson lawsuits Drugs Zimmer blood thinner prescription drugs yo SSRI blindness diet drug meningitis settlement fentanyl patch testing lorcaserin breast cancer